Mechanism of Action: UDP Glucuronosyltransferases Inducers
✉ Email this page to a colleague
Drugs with Mechanism of Action: UDP Glucuronosyltransferases Inducers
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma Ltd | RITONAVIR | ritonavir | TABLET;ORAL | 206614-001 | Sep 17, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Amneal | RITONAVIR | ritonavir | TABLET;ORAL | 208890-001 | Sep 17, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Cipla | RITONAVIR | ritonavir | TABLET;ORAL | 202573-001 | Jan 15, 2015 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Hetero Labs Ltd Iii | RITONAVIR | ritonavir | TABLET;ORAL | 204587-001 | Sep 17, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Abbvie | NORVIR | ritonavir | TABLET;ORAL | 022417-001 | Feb 10, 2010 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |